- $3.55bn
- $5.34bn
- $3.41bn
- 78
- 47
- 40
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,552 | 2,728 | 2,915 | 3,132 | 3,410 |
Cost of Revenue | |||||
Gross Profit | 883 | 834 | 967 | 996 | 1,140 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,287 | 2,581 | 2,748 | 3,146 | 3,511 |
Operating Profit | 265 | 147 | 167 | -14 | -101 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 38 | -94 | -53 | -41 | -366 |
Provision for Income Taxes | |||||
Net Income After Taxes | 22 | -103 | -73 | -72 | -362 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 22 | -103 | -60 | -62 | -345 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 22 | -103 | -60 | -62 | -345 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.148 | -0.042 | -0.046 | -0.025 | -0.389 |
Dividends per Share |